Alnylam Pharmaceuticals | ALNY - Employees Total Number

Stock Price
328.65
Daily Change
-2.22 -0.67%
Monthly
1.10%
Yearly
23.17%
Q2 Forecast
307.84

Alnylam Pharmaceuticals reported 2.23K in Employees for its fiscal year ending in December of 2024.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amgen 28K 1.3K Dec/2024
Arrowhead Research 711 102 Dec/2025
BioCryst Pharmaceuticals 536 5 Dec/2023
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Moderna 5.8K 200 Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis 101.7K 2.62K Dec/2022
PTC Therapeutics 939 49 Dec/2024
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Sangamo BioSciences 405 73 Dec/2023
Sanofi EUR 91.57K 3.87K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Takeda 47.46K 1.83K Dec/2025
Tectonic Therapeutic 45 1 Dec/2023
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024
Xencor 250 30 Dec/2024